Erteberel
CAS: 533884-09-2
Ref. 3D-IWA88409
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Erteberel is a drug that has been shown to be effective for the treatment of breast cancer. It belongs to the class of drugs known as growth factors, which are polypeptides that stimulate cell proliferation and differentiation. Erteberel is a potent inhibitor of x-ray crystal structures and epidermal growth factor receptor (EGFR) tyrosine kinase activity. Erteberel has shown potential as a target for cancer therapy because it inhibits mitochondrial superoxide production. This drug has been shown to have no effect on fertility in mice. Erteberel is being studied as a diagnostic agent for myeloid-derived suppressor cells (MDSCs), which are white blood cells that suppress immune responses and play an important role in the development of metastatic cancer.
